PlainRecalls
FDA Drug Moderate Class II Terminated

Clozapine Orally Disintegrating Tablets, 12.5 mg, 100-count bottles, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-5416-01 Yellow, round, flat-faced, beveled-edge, unscored tablet. Debossed with 13 on one side and plain on the other side.

Reported: October 10, 2018 Initiated: September 21, 2018 #D-0001-2019

Product Description

Clozapine Orally Disintegrating Tablets, 12.5 mg, 100-count bottles, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-5416-01 Yellow, round, flat-faced, beveled-edge, unscored tablet. Debossed with 13 on one side and plain on the other side.

Reason for Recall

Failed Disintegration Specifications: Out-of-specification disintegration test result obtained during routine stability testing.

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
313 bottles
Distribution
Distributed nationwide in the USA
Location
North Wales, PA

Frequently Asked Questions

What product was recalled?
Clozapine Orally Disintegrating Tablets, 12.5 mg, 100-count bottles, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-5416-01 Yellow, round, flat-faced, beveled-edge, unscored tablet. Debossed with 13 on one side and plain on the other side.. Recalled by Teva Pharmaceuticals USA. Units affected: 313 bottles.
Why was this product recalled?
Failed Disintegration Specifications: Out-of-specification disintegration test result obtained during routine stability testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 10, 2018. Severity: Moderate. Recall number: D-0001-2019.